4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-19-004274
Chief Medical Officer acquired 2,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Benaim Ely · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-28 | Exercise or conversion : show line 1 in the form | +2,375 | 4,750 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-28 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −2,375 | 4,750 | D |
Loading xslF345X03/form4.xml…